BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23184753)

  • 1. Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
    Epler K; Padilla D; Phillips G; Crowder P; Castillo R; Wilkinson D; Wilkinson B; Burgard C; Kalinich R; Townson J; Chackerian B; Willman C; Peabody D; Wharton W; Brinker CJ; Ashley C; Carnes E
    Adv Healthc Mater; 2012 May; 1(3):348-53. PubMed ID: 23184753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.
    Ashley CE; Carnes EC; Phillips GK; Padilla D; Durfee PN; Brown PA; Hanna TN; Liu J; Phillips B; Carter MB; Carroll NJ; Jiang X; Dunphy DR; Willman CL; Petsev DN; Evans DG; Parikh AN; Chackerian B; Wharton W; Peabody DS; Brinker CJ
    Nat Mater; 2011 May; 10(5):389-97. PubMed ID: 21499315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
    Butler KS; Durfee PN; Theron C; Ashley CE; Carnes EC; Brinker CJ
    Small; 2016 Apr; 12(16):2173-85. PubMed ID: 26780591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.
    Ashley CE; Carnes EC; Epler KE; Padilla DP; Phillips GK; Castillo RE; Wilkinson DC; Wilkinson BS; Burgard CA; Kalinich RM; Townson JL; Chackerian B; Willman CL; Peabody DS; Wharton W; Brinker CJ
    ACS Nano; 2012 Mar; 6(3):2174-88. PubMed ID: 22309035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons.
    Gonzalez Porras MA; Durfee P; Giambini S; Sieck GC; Brinker CJ; Mantilla CB
    Nanomedicine; 2018 Apr; 14(3):661-672. PubMed ID: 29339186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
    Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles.
    Liu J; Stace-Naughton A; Jiang X; Brinker CJ
    J Am Chem Soc; 2009 Feb; 131(4):1354-5. PubMed ID: 19173660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
    Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.
    Yang S; Zhang B; Zhao X; Zhang M; Zhang M; Cui L; Zhang L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma.
    Liu M; Tu J; Feng Y; Zhang J; Wu J
    J Nanobiotechnology; 2020 Aug; 18(1):114. PubMed ID: 32811502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
    Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
    Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy.
    Xuan M; Shao J; Dai L; He Q; Li J
    Adv Healthc Mater; 2015 Aug; 4(11):1645-52. PubMed ID: 25960053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Bilayer-Gated Mesoporous Silica Nanocarriers for Tumor-Targeted Delivery of Zoledronic Acid in Vivo.
    Desai D; Zhang J; Sandholm J; Lehtimäki J; Grönroos T; Tuomela J; Rosenholm JM
    Mol Pharm; 2017 Sep; 14(9):3218-3227. PubMed ID: 28737925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells.
    Durfee PN; Lin YS; Dunphy DR; Muñiz AJ; Butler KS; Humphrey KR; Lokke AJ; Agola JO; Chou SS; Chen IM; Wharton W; Townson JL; Willman CL; Brinker CJ
    ACS Nano; 2016 Sep; 10(9):8325-45. PubMed ID: 27419663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPMV-induced synthesis of hollow mesoporous SiO2 nanocapsules with excellent performance in drug delivery.
    Kumar K; Kumar Doddi S; Arunasree MK; Paik P
    Dalton Trans; 2015 Mar; 44(9):4308-17. PubMed ID: 25640798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake.
    Cauda V; Engelke H; Sauer A; Arcizet D; Bräuchle C; Rädler J; Bein T
    Nano Lett; 2010 Jul; 10(7):2484-92. PubMed ID: 20515041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.